i'm not sure if they cover this in the paper, but is there a reason they want to administer a prodrug at all? why not just give the API and you wouldn't have metabolism issue etc.
I think that will depend on the setting and application of therapy. I believe determining what will be most efficient for each individual patient will be more difficult.
Saw this article a while ago. It's great that you've made an easy to understand video on it!
Very informative about the lab methods used in this type of research, many thanks
i'm not sure if they cover this in the paper, but is there a reason they want to administer a prodrug at all? why not just give the API and you wouldn't have metabolism issue etc.
There is still the question if a shorter psilocin exposure can have the same therapeutic effect, which I doubt
I think that will depend on the setting and application of therapy. I believe determining what will be most efficient for each individual patient will be more difficult.